STAT+: Pharmalittle: We’re reading about a Merck AI deal, China and the pharma supply chain, and more
Merck is partnering with Isomorphic Labs, an AI drug discovery company built on Nobel Prize-winning technology, for a research collaboration. The partnership combines pharmaceutical expertise with advanced AI capabilities for drug development.
Why it matters: AI-driven drug discovery partnerships could accelerate the development of new therapeutics, potentially bringing treatments to patients faster and at lower development costs.
SourceSTAT News




















